Xlife Sciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Oliver Baumann

Chief executive officer

CHF597.2k

Total compensation

CEO salary percentage51.0%
CEO tenure3.8yrs
CEO ownershipn/a
Management average tenure1.9yrs
Board average tenure1.8yrs

Recent management updates

Recent updates

Xlife Sciences' (VTX:XLS) Problems Go Beyond Weak Profit

Apr 28
Xlife Sciences' (VTX:XLS) Problems Go Beyond Weak Profit

CEO Compensation Analysis

How has Oliver Baumann's remuneration changed compared to Xlife Sciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2023n/an/a

CHF16m

Mar 31 2023n/an/a

CHF15m

Dec 31 2022CHF597kCHF305k

CHF14m

Sep 30 2022n/an/a

CHF32m

Jun 30 2022n/an/a

CHF49m

Mar 31 2022n/an/a

CHF51m

Dec 31 2021CHF1mCHF284k

CHF53m

Compensation vs Market: Oliver's total compensation ($USD662.23K) is about average for companies of similar size in the Swiss market ($USD930.67K).

Compensation vs Earnings: Oliver's compensation has been consistent with company performance over the past year.


CEO

Oliver Baumann

3.8yrs

Tenure

CHF597,230

Compensation

Mr. Oliver R. Baumann serves as Chief Executive Officer at Xlife Sciences AG. He serves as Director at Xlife Sciences AG since June 17, 2020. He is a certified banking economist and passionate entrepreneur...


Leadership Team

NamePositionTenureCompensationOwnership
Oliver Baumann
CEO & Executive Directorno dataCHF597.23kno data
Christian Faber
Chief Compliance Officer and Head of Legal & Compliance2.2yrsCHF50.69kno data
Carl Halem
Chief Financial Officer2.3yrsno datano data
Beat Klaui
Head of Accounting & Taxation3.2yrsno datano data
Alexander Zink
Head of Technology & Innovation1.2yrsno datano data
Frank Ploger
Chief Scientific Officer3.3yrsno datano data
Christoph Antz
Chief Executive Officer of VERAXA Biotech GmbH1.6yrsno datano data
Matthias Steffen
Managing Director of FUSE-AI GmbHno datano datano data
Jenny Nisser
Managing Director of Saniva Diagnostics GmbHless than a yearno datano data
Simone Bonito
Head of Backoffice1.2yrsno datano data

1.9yrs

Average Tenure

Experienced Management: XLS's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Oliver Baumann
CEO & Executive Director3.8yrsCHF597.23kno data
Hans-Georg Rammensee
Member of the Advisory Boardno datano datano data
Michael Klein
Member of the Advisory Boardno dataCHF24.43kno data
Ernst Rietschel
Member of the Advisory Boardno datano datano data
Johannes Schumacher
Member of the Advisory Boardno datano datano data
Ralf Oettmeier
Member of the Advisory Boardno datano datano data
Uwe Rudolf Reuter
Member of the Advisory Boardno datano datano data
Christoph Brucher
Member of the Advisory Boardno datano datano data
Mark Muller
Non-Executive Independent Director5.4yrsCHF62.28kno data
David Deck
President of the Board of Directors1.8yrsCHF17.83kno data
Desiree Dosch
Independent Non-Executive Director1.8yrsCHF23.18kno data
Norbert Windhab
Chairman of Advisory Board & Non-Executive Director1.8yrsCHF23.18kno data

1.8yrs

Average Tenure

Experienced Board: XLS's board of directors are not considered experienced ( 1.8 years average tenure), which suggests a new board.


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.